Treatment with IFN-γ-1b reduces BAL CXCL8 levels in IPF patients, indicating a potential role for IFN-γ as a modulator of angiogenic pathways during IPF [242]. The gene discussed is CXCL8; the disease is idiopathic pulmonary fibrosis.